Getting to Target Safely: Newer long-acting basal insulin analogues for managing type 2 diabetes (T2D) (Basal Insulin Practice Project) – Mainpro+
CAN-eng
$0
gratuit
Mainpro+
Diabète
1 Credits
Description du cours
Détails du cours
Date d'expiration : 2018-08-15
Métiers: Médecin
Faculté
Accréditation
Objectif(s) d'apprentissage
After completion of the program, participants will be able to:
- Define key targets to aim for in patients with type 2 diabetes;
- Address misconceptions around hypoglycemia in patients with type 2 diabetes taking insulin;
- Discuss the newer long-acting insulins and their ability to control blood glucose in type 2 diabetes;
- Explain the impact of newer long-acting insulins on the risk for hypoglycemia.